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Immune Regulation by  
Histamine H4 Receptors in Skin
Cezmi A. Akdis1
The diverse effects of histamine on immune regulation appear to be due to dif-
ferential expression and regulation of four types of histamine receptors and their 
distinct intracellular signals. The differences in cellular expression and affinities of 
these receptors for histamine determine the biological effects of histamine and 
the drugs that target histamine receptors. In this issue, Dijkstra et al. demonstrate 
the expression and some of the functions of histamine H4 receptors on inflam-
matory dendritic cells in atopic dermatitis skin.
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Histamine is synthesized from L-
histidine exclusively by histidine decar-
boxylase, an enzyme expressed in cells 
throughout the body, including cen-
tral nervous system neurons, gastric 
mucosa parietal cells, mast cells, and 
basophils (Akdis and Simons, 2006; 
Jutel et al., 2002). Although contrast-
ing findings have been reported, the 
histamine H1-receptor (H1R) stimulates 
cells of the immune system by poten-
tiating their proinflammatory activity 
through increased migration to areas of 
inflammation, as well as by increasing 
their effector function. The histamine 
H2-receptor (H2R), on the other hand, 
appears to be a potent suppressor of 
inflammatory and effector function. 
Histamine modulates neurotransmitter 
release through presynaptic hista-
mine H3-receptors (H3R) located on 
histaminergic and nonhistaminergic 
neurons in the central and peripheral 
nervous systems, and it facilitates sev-
eral proinflammatory activities through 
the novel histamine H4-receptor (H4R). 
Differences in cellular expression and 
affinities of these receptors for hista-
mine determine the biological effects 
of histamine and the drugs that target 
histamine receptors. H1R and H2R have 
a low affinity in the micromolar range, 
whereas H3R and H4R are high-affin-
ity histamine receptors, with affinities 
of 5–10 nM (Akdis and Simons, 2006; 
Thurmond et al., 2008).
Histamine contributes to the progres-
sion of allergic-inflammatory responses 
by enhancing the secretion of proinflam-
matory cytokines such as IL-1α, IL-1β, 
and IL-6, as well as chemokines such as 
RANTES and IL-8, by several cell types 
and in local tissues (Bayram et al., 1999; 
Jeannin et al., 1994; Meretey et al., 1991; 
Vannier and Dinarello, 1993). Histamine 
possesses all the properties of a classic 
leukocyte chemoattractant, including 
agonist-induced actin polymerization, 
mobilization of intracellular calcium, 
alterations in cell shape, and upregula-
tion of adhesion molecule expression. 
Histamine induces the CC chemokines, 
monocyte chemotactic proteins 1 and 3, 
RANTES, and eotaxin in explant cultures 
of human nasal mucosa via H1R, sug-
gesting a prolonged inflammatory cycle 
in allergic rhinitis between the cells that 
release histamine and their enhanced 
migration to nasal mucosa (Fujikura et 
al., 2001). In an allergen-induced lung-
inflammation model in mice, allergen-
specific wild-type but not H1R-deficient 
CD4+ T cells were recruited to the lungs 
of naive recipients following inhaled 
allergen challenge (Bryce et al., 2006).
Histamine exerts a range of effects 
on many physiologic and pathologic 
processes, and new roles are still being 
discovered. In lesional skin of patients 
with atopic dermatitis (AD), a special 
DC type—the inflammatory dendritic 
epidermal cell (IDEC)—is characterized 
by the expression of both the low-affinity 
IgE receptor (CD23, FcεRII) and the high-
affinity IgE receptor (FcεRI) (Wollenberg 
and Klein, 2007). These cells disappear 
with successful topical treatment of the 
skin. Because of the importance of IDECs 
in the pathogenesis of AD and a possible 
interaction of histamine and IDECs in 
lesions of AD, Dijkstra et al. (2008, this 
issue) investigated the expression and 
function of H4R on IDECs. The authors 
demonstrate that skin IDECs express H4R 
at the protein level, as shown by flow 
cytometry of epidermal cell suspensions 
and immunofluorescence staining of skin 
sections from lesional skin of AD patients. 
The expression of H4R on monocyte-
derived IDECs was upregulated by inter-
feron-γ, but not by IL-4, tumor necrosis 
factor-α, poly I:C, or combinations of 
these, thus demonstrating that H4R has 
a role in a T helper 1 (Th1)–related cyto-
kine environment in the skin. Previously, 
high CCL2 levels have been linked to 
Th2 responses. The upregulation of H4R 
by IFN-γ,� together with the downregula-
tion of CCL2 by H4R agonists, suggests, a 
role for H4R in Th1 responses. It has been 
demonstrated that differential patterns 
of histamine receptor expression on Th1 
and Th2 cells determine reciprocal T-cell 
responses following histamine stimula-
tion (Jutel et al., 2001). Th1 cells show 
predominant, but not exclusive, expres-
sion of H1R, whereas Th2 cells show 
increased expression of H2R. Histamine 
enhances Th1-type responses by trigger-
ing H1R, whereas both Th1- and Th2-
type responses are negatively regulated 
by H2R (Jutel et al., 2001). The work of 
Dijkstra et al. suggests that downregula-
tion of CCL2 and upregulation of IFN-γ 
by H4R may contribute to the shift from a 
Th2 to a Th1 milieu, as seen in the tran-
sition from acute to chronic lesions of 
AD (Dijkstra et al., 2008). It seems that 
H1R and H4R synergize in this process, 
in which the upregulation of IFN-γ in 
T cells leads to keratinocyte apoptosis 
and eczema formation in AD (Trautmann 
et al., 2000).
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Histamine participates in activat-
ing dendritic cell precursors, as well 
as both immature and mature forms. 
Dendritic cells express all four hista-
mine receptors (Caron et al., 2001a; 
Gutzmer et al., 2002; Idzko et al., 
2002). Some H4R-mediated effects of 
histamine on antigen-presenting cells 
have been previously demonstrated 
by the same group, for example, IL-
12 downregulation in human Mo-
DCs (Gutzmer et al., 2005) and CCL2 
downregulation in human monocytes 
(Dijkstra et al., 2007). Endogenous his-
tamine is actively synthesized during 
cytokine-induced dendritic cell dif-
ferentiation (Szeberenyi et al., 2001). 
Dendritic cells mature from monocytic 
and lymphoid precursors and acquire 
dendritic cell 1 and 2 phenotypes, 
which in turn facilitate the develop-
ment of Th1 and Th2 cells, respec-
tively. In the differentiation process of 
monocyte-derived dendritic cells, H1R 
and H3R act as positive stimulants that 
increase antigen-presentation capacity 
and Th1 priming activity. In contrast, 
H2R acts as a suppressive molecule 
for antigen presentation, enhancing 
IL-10 production and inducing IL-10-
producing T cells or Th2 cells (Caron 
et al., 2001b; Mazzoni et al., 2001; 
van der Pouw Kraan et al., 1998). 
Maturation of dendritic cells results in 
the loss of these responses. In matur-
ing dendritic cells, however, histamine 
dose-dependently increases intracel-
lular cAMP levels and stimulates IL-10 
secretion, while inhibiting produc-
tion of IL-12 via H2R (Mazzoni et al., 
2001). Interestingly, although human 
monocyte-derived dendritic cells 
express both H1R and H2R and can 
induce CD86 expression by histamine, 
human epidermal Langerhans cells 
express neither H1R nor H2R, mainly 
because of the effect of transforming 
growth factor-β (Ohtani et al., 2003).
In conclusion, the immune regula-
tory functions of histamine are excit-
ing and important, and new data are 
emerging. Histamine and the four his-
tamine receptors constitute a multifac-
eted system, with distinct functions of 
receptor types due to their differential 
expression, which changes according 
to the stage of cell differentiation with 
influence from the microenvironment. 
New data on the novel functions of H4R 
have opened an exciting new window 
and may lead to new understanding 
and novel therapies to treat allergic and 
other inflammatory diseases.
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